117 related articles for article (PubMed ID: 21092993)
1. Pericardial effusions in the cancer population: prognostic factors after pericardial window and the impact of paradoxical hemodynamic instability.
Wagner PL; McAleer E; Stillwell E; Bott M; Rusch VW; Schaffer W; Huang J
J Thorac Cardiovasc Surg; 2011 Jan; 141(1):34-8. PubMed ID: 21092993
[TBL] [Abstract][Full Text] [Related]
2. Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions.
Çelik S; Lestuzzi C; Cervesato E; Dequanter D; Piotti P; De Biasio M; Imazio M
J Thorac Cardiovasc Surg; 2014 Nov; 148(5):2288-93. PubMed ID: 24836991
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and prognosis of initial pericardiocentesis in the primary management of malignant pericardial effusion.
Apodaca-Cruz A; Villarreal-Garza C; Torres-Avila B; Torres J; Meneses A; Flores-Estrada D; Lara-Medina F; Arrieta O
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):154-61. PubMed ID: 20504889
[TBL] [Abstract][Full Text] [Related]
4. Risk factors affecting the survival rate in patients with symptomatic pericardial effusion undergoing surgical intervention.
Mirhosseini SM; Fakhri M; Mozaffary A; Lotfaliany M; Behzadnia N; Ansari Aval Z; Ghiasi SM; Boloursaz MR; Masjedi MR
Interact Cardiovasc Thorac Surg; 2013 Apr; 16(4):495-500. PubMed ID: 23250960
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of symptomatic pericardial effusion in patients with solid malignancies.
Gross JL; Younes RN; Deheinzelin D; Diniz AL; Silva RA; Haddad FJ
Ann Surg Oncol; 2006 Dec; 13(12):1732-8. PubMed ID: 17028771
[TBL] [Abstract][Full Text] [Related]
6. Severe pericardial effusion in patients with concurrent malignancy: a retrospective analysis of prognostic factors influencing survival.
Dequanter D; Lothaire P; Berghmans T; Sculier JP
Ann Surg Oncol; 2008 Nov; 15(11):3268-71. PubMed ID: 18648881
[TBL] [Abstract][Full Text] [Related]
7. Mid-Term Efficacy of Subxiphoid Versus Transpleural Pericardial Window for Pericardial Effusion.
Balla S; Zea-Vera R; Kaplan RA; Rosengart TK; Wall MJ; Ghanta RK
J Surg Res; 2020 Aug; 252():9-15. PubMed ID: 32213328
[TBL] [Abstract][Full Text] [Related]
8. Ten-year surgical experience with nontraumatic pericardial effusions: a comparison between the subxyphoid and transthoracic approaches to pericardial window.
Liberman M; Labos C; Sampalis JS; Sheiner NM; Mulder DS
Arch Surg; 2005 Feb; 140(2):191-5. PubMed ID: 15724002
[TBL] [Abstract][Full Text] [Related]
9. Subxiphoid pericardiostomy in the management of pericardial effusions.
Lema LE; Mcharo ON
East Afr Med J; 1991 Apr; 68(4):270-5. PubMed ID: 1914977
[TBL] [Abstract][Full Text] [Related]
10. Primary percutaneous balloon pericardiotomy for malignant pericardial effusion.
Swanson N; Mirza I; Wijesinghe N; Devlin G
Catheter Cardiovasc Interv; 2008 Mar; 71(4):504-7. PubMed ID: 18307242
[TBL] [Abstract][Full Text] [Related]
11. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions.
Girardi LN; Ginsberg RJ; Burt ME
Ann Thorac Surg; 1997 Nov; 64(5):1422-7; discussion 1427-8. PubMed ID: 9386714
[TBL] [Abstract][Full Text] [Related]
12. Predictors of hospital discharge in cancer patients with pericardial effusion undergoing surgical pericardial drainage.
Kazantzis T; Bibas BJ; Dela-Vega AJ; Nabuco P; Lauricella LL; Pêgo-Fernandes PM; Terra RM
J Surg Oncol; 2019 Jan; 119(1):143-147. PubMed ID: 30466137
[TBL] [Abstract][Full Text] [Related]
13. Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management.
Ashikhmina EA; Schaff HV; Sinak LJ; Li Z; Dearani JA; Suri RM; Park SJ; Orszulak TA; Sundt TM
Ann Thorac Surg; 2010 Jan; 89(1):112-8. PubMed ID: 20103217
[TBL] [Abstract][Full Text] [Related]
14. Subxiphoid pericardiastomy in the management of pericardial effusions.
Lema LE; Mchara ON
Cent Afr J Med; 1991 Aug; 37(8):265-8. PubMed ID: 1807802
[TBL] [Abstract][Full Text] [Related]
15. Subxiphoid pericardial window for pericardial effusive disease.
Mills SA; Julian S; Holliday RH; Vinten-Johansen J; Case LD; Hudspeth AS; Tucker WY; Cordell AR
J Cardiovasc Surg (Torino); 1989; 30(5):768-73. PubMed ID: 2681217
[TBL] [Abstract][Full Text] [Related]
16. Determinants of Survival After Emergency Intrapericardial Cisplatin Treatment in Cancer Patients with Recurrent Hemodynamic Instability After Pericardiocentesis.
Darocha S; Wilk M; Walaszkowska-Czyż A; Kępski J; Mańczak R; Kurzyna M; Torbicki A; Szmit S
In Vivo; 2018; 32(2):373-379. PubMed ID: 29475923
[TBL] [Abstract][Full Text] [Related]
17. [Subxiphoid pericardial window drainage in the management of large pericardial effusions].
Miao Q; Yu H; Ren H; Wang Z; Shen W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):216-9. PubMed ID: 11367709
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors affecting survival of patients with cancer-related pericardial effusion managed by surgery.
Jeon HW; Cho DG; Park JK; Hyun KY; Choi SY; Suh JH; Kim YD
World J Surg Oncol; 2014 Aug; 12():249. PubMed ID: 25091001
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic pericardio-peritoneal window: an alternative approach in the treatment of recurrent pericardial effusion, in-hospital evolution and survival.
Staltari D; Diaz A; Capellino P; Benavides F; Ramos R; Pierini L; Morales I
Surg Laparosc Endosc Percutan Tech; 2007 Apr; 17(2):116-9. PubMed ID: 17450093
[TBL] [Abstract][Full Text] [Related]
20. [Subxiphoid drainage of pericardial effusions].
Alegre RA; Nieto R
Rev Med Panama; 1993 May; 18(2):140-4. PubMed ID: 8327744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
